EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Artificial Intelligence in Lung Cancer Screening: The Future Is Now

Michaela Cellina iD, Laura Maria Cacioppa, Maurizio Cè iD, Vittoria Chiarpenello, Marco Costa, Zakaria Vincenzo, Daniele Pais iD, Maria Vittoria Bausano, Nicolò Rossini, Alessandra Bruno, Chiara Floridi

Cancers · 30.08.2023 · 15 (17) · 4344

DOI: 10.3390/cancers15174344 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 30.08.2023. Verfasst von Michaela Cellina und 10 weiteren Autor:innen. Beteiligte Einrichtung: Radiology Department, Fatebenefratelli Hospital, ASST Fatebenefratelli Sacco, 20121 Milano, Italy. Die Arbeit wurde bisher 158-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer has one of the worst morbidity and fatality rates of any malignant tumour. Most lung cancers are discovered in the middle and late stages of the disease, when treatment choices are limited, and patients’ survival rate is low. The aim of lung cancer screening is the identification of lung malignancies in the early stage of the disease, when more options for effective treatments are available, to improve the patients’ outcomes. The desire to improve the efficacy and efficiency of clinical care continues to drive multiple innovations into practice for better patient management, and in this context, artificial intelligence (AI) plays a key role. AI may have a role in each process of the lung cancer screening workflow. First, in the acquisition of low-dose computed tomography for screening programs, AI-based reconstruction allows a further dose reduction, while still maintaining an optimal image quality. AI can help the personalization of screening programs through risk stratification based on the collection and analysis of a huge amount of imaging and clinical data. A computer-aided detection (CAD) system provides automatic detection of potential lung nodules with high sensitivity, working as a concurrent or second reader and reducing the time needed for image interpretation. Once a nodule has been detected, it should be characterized as benign or malignant. Two AI-based approaches are available to perform this task: the first one is represented by automatic segmentation with a consequent assessment of the lesion size, volume, and densitometric features; the second consists of segmentation first, followed by radiomic features extraction to characterize the whole abnormalities providing the so-called “virtual biopsy”. This narrative review aims to provide an overview of all possible AI applications in lung cancer screening.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligencecomputer-aided detectiondeep learninglung cancerlung cancer screeninglung nodulepersonalized medicinepersonalized screening programsradiomicsegmentationvirtual biopsy

Autor:innen und Institutionen

  • Radiology Department, Fatebenefratelli Hospital, ASST Fatebenefratelli Sacco, 20121 Milano, Italy.
  • Department of Clinical, Special and Dental Sciences, University Politecnica delle Marche, 60126 Ancona, Italy.
  • Division of Interventional Radiology, Department of Radiological Sciences, University Hospital "Azienda Ospedaliera Universitaria delle Marche", 60126 Ancona, Italy.
  • Postgraduation School in Radiodiagnostics, Università degli Studi di Milano, 20122 Milan, Italy.
  • Division of Radiology, Department of Radiological Sciences, University Hospital "Azienda Ospedaliera Universitaria delle Marche", 60126 Ancona, Italy.

ORCID-Profile: Michaela Cellina, Maurizio Cè, Daniele Pais

Zitieren

APA

Cellina, M., Cacioppa, L. M., Cè, M., Chiarpenello, V., Costa, M., Vincenzo, Z., Pais, D., Bausano, M. V., Rossini, N., Bruno, A., & Floridi, C. (2023). Artificial Intelligence in Lung Cancer Screening: The Future Is Now. Cancers, 15(17), 4344. https://doi.org/10.3390/cancers15174344

Vancouver

Cellina M, Cacioppa LM, Cè M, Chiarpenello V, Costa M, Vincenzo Z, et al. Artificial Intelligence in Lung Cancer Screening: The Future Is Now. Cancers. 2023;15(17):4344. doi:10.3390/cancers15174344

BibTeX
@article{Cellina2023,
  author = {Cellina, Michaela and Cacioppa, Laura Maria and Cè, Maurizio and Chiarpenello, Vittoria and Costa, Marco and Vincenzo, Zakaria and Pais, Daniele and Bausano, Maria Vittoria and Rossini, Nicolò and Bruno, Alessandra and Floridi, Chiara},
  title = {Artificial Intelligence in Lung Cancer Screening: The Future Is Now},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {17},
  pages = {4344},
  doi = {10.3390/cancers15174344}
}
Kostenlos starten →